Article Information
History
- September 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Danyal Ibrahim, MD, MPH1,*,
- Latha Dulipsingh, MD2,
- Lisa Zapatka, MSN3,
- Reginald Eadie, MD4,
- Rebecca Crowell, PhD5,
- Kendra Williams, BS6,
- Dorothy B. Wakefield, MS7,
- Lisa Cook, BSN8,
- Jennifer Puff, BSN9 and
- Syed A. Hussain, MD10
- 1Trinity Health Of New England, Hartford, Connecticut, USA
- 2Diabetes Center, Saint Francis Hospital, Hartford, Connecticut, USA
- 3Trinity Health Of New England, Hartford
- 4Trinity Health Of New England, Hartford
- 5Research Department, Saint Francis Hospital, Hartford
- 6Research Department, Saint Francis Hospital, Hartford
- 7Research Department, Saint Francis Hospital, Hartford
- 8Diabetes Center, Saint Francis Hospital, Hartford
- 9Diabetes Center, Saint Francis Hospital, Hartford
- 10Trinity Health Of New England, Hartford
- ↵*
Corresponding author
Danyal Ibrahim, M.D., M.P.H. Trinity Health Of New England, 114 Woodland Street, Hartford, CT 06105, Tel 860-794-5886, Fax 860-714-5769, Email: dibrahim{at}trinityhealthofne.org
Posted September 01, 2020.
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial
